Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende
Erweiterte Suche
Anmelden
nach oben
Current Heart Failure Reports
Erschienen in: Current Heart Failure Reports 2/2015

01.04.2015 | Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

Current Practice in Patient Selecting for Long-Term Mechanical Circulatory Support

verfasst von: M. S. Halbreiner, E. Soltesz, R. Starling, N. Moazami

Erschienen in: Current Heart Failure Reports | Ausgabe 2/2015

Einloggen, um Zugang zu erhalten

Abstract

With the advances of mechanical circulatory support, the selection of patients has undergone many changes over the last decade. Determining who is suitable for left ventricular assist device (LVAD) implantation is important to understanding the overall risk and outcomes. As devices improve, it is expected that changes will continue in this field. This review describes current state of patient selection, evaluation, and optimization prior to implantation of a long-term circulatory support device.
Literatur
1.••
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson LW, Blume ED, et al. Sixth INTERMACS annual report: a 10,000-patient database. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2014;33:555–64. Most recent report on over 10,000 patients with LVADS including their risk factors, demographics and outcomes.CrossRef
2.
Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE, Drazner MH, et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol. 2013;62:e147–239.CrossRefPubMed
3.
Metra M, Ponikowski P, Dickstein K, McMurray JJV, Gavazzi A, Bergh C-H, et al. Advanced chronic heart failure: a position statement from the Study Group on Advanced Heart Failure of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2007;9:684–94.CrossRefPubMed
4.••
Feldman D, Pamboukian SV, Teuteberg JJ, Birks E, Lietz K, Moore SA, et al. The 2013 International Society for Heart and Lung Transplantation Guidelines for mechanical circulatory support: executive summary. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2013;32:157–87. Most recent ISHLT guidelines for use of mechanical support.CrossRef
5.
Holman WL. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS): what have we learned and what will we learn? Circulation. 2012;126:1401–6.CrossRefPubMed
6.
Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, et al. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2009;28:535–41.CrossRef
7.
Shah KB, Thanavaro KL, Tang DG, Kasirajan V. Clinical outcomes for INTERMACS profile 1 patient implanted with the total artificial heart. J Heart Lung Transplant. 2013;32:S236.CrossRef
8.
Alba AC, Rao V, Ivanov J, Ross HJ, Delgado DH. Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2009;28:827–33.CrossRef
9.
Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Stevenson L, Miller M, et al. Long-term mechanical circulatory support (destination therapy): on track to compete with heart transplantation? J Thorac Cardiovasc Surg. 2012;144:584–603. discussion 597–598.CrossRefPubMedCentralPubMed
10.
Baldwin JT, Mann DL. NHLBI’s program for VAD therapy for moderately advanced heart failure: the REVIVE-IT pilot trial. J Card Fail. 2010;16:855–8.CrossRefPubMedCentralPubMed
11.•
Slaughter MS, Meyer AL, Birks EJ. Destination therapy with left ventricular assist devices: patient selection and outcomes. Curr Opin Cardiol. 2011;26:232–6. Great review of how LVAD therapy and technology has improved in the use of the device for destination therapy.CrossRefPubMed
12.•
Steffen RJ, Halbreiner MS, Zhang L, Fukamachi K, Soltesz EG, Starling RC, et al. Mechanical circulatory support for the right ventricle in the setting of a left ventricular assist device. Exp Rev Med Devices. 2014;11:587–93. Great summary of the importance of the RV in the setting of the need for LVAD implantation.CrossRef
13.
Moazami N, Pasque MK, Moon MR, Herren RL, Bailey MS, Lawton JS, et al. Mechanical support for isolated right ventricular failure in patients after cardiotomy. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2004;23:1371–5.CrossRef
14.•
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr Off Publ Am Soc Echocardiogr. 2010;23:685–713. quiz 786–788. Summary of guidelines outlining assessement of RV function as it is vitally important to LVAD consideration.CrossRef
15.
16.
Atluri P, Goldstone AB, Fairman AS, MacArthur JW, Shudo Y, Cohen JE, et al. Predicting right ventricular failure in the modern, continuous flow left ventricular assist device era. Ann Thorac Surg. 2013;96:857–63. discussion 863–864.CrossRefPubMedCentralPubMed
17.
Kormos RL, Teuteberg JJ, Pagani FD, Russell SD, John R, Miller LW, et al. Right ventricular failure in patients with the HeartMate II continuous-flow left ventricular assist device: incidence, risk factors, and effect on outcomes. J Thorac Cardiovasc Surg. 2010;139:1316–24.CrossRefPubMed
18.
Grant ADM, Smedira NG, Starling RC, Marwick TH. Independent and incremental role of quantitative right ventricular evaluation for the prediction of right ventricular failure after left ventricular assist device implantation. J Am Coll Cardiol. 2012;60:521–8.CrossRefPubMed
19.
John R, Mantz K, Eckman P, Rose A, May-Newman K. Aortic valve pathophysiology during left ventricular assist device support. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2010;29:1321–9.CrossRef
20.
Adamson RM, Dembitsky WP, Baradarian S, Chammas J, May-Newman K, Chillcott S, et al. Aortic valve closure associated with HeartMate left ventricular device support: technical considerations and long-term results. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2011;30:576–82.CrossRef
21.
Park SJ, Liao KK, Segurola R, Madhu KP, Miller LW. Management of aortic insufficiency in patients with left ventricular assist devices: a simple coaptation stitch method (Park’s stitch). J Thorac Cardiovasc Surg. 2004;127:264–6.CrossRefPubMed
22.
Wang TS, Hernandez AF, Felker GM, Milano CA, Rogers JG, Patel CB. Valvular heart disease in patients supported with left ventricular assist devices. Circ Heart Fail. 2014;7:215–22.CrossRefPubMed
23.
Aaronson KD, Patel H, Pagani FD. Patient selection for left ventricular assist device therapy. Ann Thorac Surg. 2003;75:S29–35.CrossRefPubMed
24.
Peura JL, Colvin-Adams M, Francis GS, Grady KL, Hoffman TM, Jessup M, et al. Recommendations for the use of mechanical circulatory support: device strategies and patient selection: a scientific statement from the American Heart Association. Circulation. 2012;126:2648–67.CrossRefPubMed
25.
Piacentino V, Williams ML, Depp T, Garcia-Huerta K, Blue L, Lodge AJ, et al. Impact of tricuspid valve regurgitation in patients treated with implantable left ventricular assist devices. Ann Thorac Surg. 2011;91:1342–6. discussion 1346–1347.CrossRefPubMed
26.
Robertson JO, Grau-Sepulveda MV, Okada S, O’Brien SM, Matthew Brennan J, Shah AS, et al. Concomitant tricuspid valve surgery during implantation of continuous-flow left ventricular assist devices: a Society of Thoracic Surgeons database analysis. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2014;33:609–17.CrossRef
27.
28.
Moazami N, Feldman D. Rethinking the terminology of mechanical circulatory support. J Thorac Cardiovasc Surg. 2012;144:2–3.CrossRefPubMed
29.
Teuteberg JJ, Stewart GC, Jessup M, Kormos RL, Sun B, Frazier OH, et al. Implant strategies change over time and impact outcomes: insights from the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). JACC Heart Fail. 2013;1:369–78.CrossRefPubMed
30.
Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, et al. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med. 2001;345:1435–43.CrossRefPubMed
31.
Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, et al. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med. 2009;361:2241–51.CrossRefPubMed
32.
Boyle AJ, Ascheim DD, Russo MJ, Kormos RL, John R, Naka Y, et al. Clinical outcomes for continuous-flow left ventricular assist device patients stratified by pre-operative INTERMACS classification. J Heart Lung Transplant Off Publ Int Soc Heart Transplant. 2011;30:402–7.CrossRef
33.
Miller LW, Pagani FD, Russell SD, John R, Boyle AJ, Aaronson KD, et al. Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med. 2007;357:885–96.CrossRefPubMed
34.
Riebandt J, Haberl T, Mahr S, Laufer G, Rajek A, Steinlechner B, et al. Preoperative patient optimization using extracorporeal life support improves outcomes of INTERMACS Level I patients receiving a permanent ventricular assist device†. Eur J Cardiothorac Surg Off J Eur Assoc Cardiothorac Surg. 2014;46:486–92.CrossRef
35.
Tsiouris A, Morgan JA, Nemeh HW, Hodari A, Shah R, Brewer RJ, et al. Does elective or emergent operative status influence outcomes in patients undergoing implantation of left ventricular assist devices? Heart Surg Forum. 2014;17:E64–72.CrossRefPubMed
36.
Trivedi JR, Cheng A, Singh R, Williams ML, Slaughter MS. Survival on the heart transplant waiting list: impact of continuous flow left ventricular assist device as bridge to transplant. Ann Thorac Surg. 2014;98:830–4.CrossRefPubMed
Metadaten
Titel
Current Practice in Patient Selecting for Long-Term Mechanical Circulatory Support
verfasst von
M. S. Halbreiner
E. Soltesz
R. Starling
N. Moazami
Publikationsdatum
01.04.2015
Verlag
Springer US
Erschienen in
Current Heart Failure Reports / Ausgabe 2/2015
Print ISSN: 1546-9530
Elektronische ISSN: 1546-9549
DOI
https://doi.org/10.1007/s11897-014-0243-3

Weitere Artikel der Ausgabe 2/2015

Current Heart Failure Reports 2/2015 Zur Ausgabe

Pharmacologic Therapy (WHW Tang, Section Editor)

Oral Sodium and Potassium Binders in Heart Failure

Pathophysiology: Neuroendocrine, Vascular, and Metabolic Factors (SD Katz, Section Editor)

Pathophysiology of Sepsis-Related Cardiac Dysfunction: Driven by Inflammation, Energy Mismanagement, or Both?

Self-Care and Health Outcomes (T Jaarsma, Section Editor)

Technology-Assisted Congestive Heart Failure Care

Nonpharmacologic Therapy: Surgery, Ventricular Assist Devices, Biventricular Pacing, and Exercise (AK Hasan, Section Editor)

The Benefits of Revascularization in Chronic Heart Failure

Epidemiology of Heart Failure (JE Ho, Section Editor)

Heart Failure in Women

Management of Heart Failure (TE Meyer, Section Editor)

Tricuspid Valve Incompetence Following Implantation of Ventricular Leads

Neu im Fachgebiet Kardiologie

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise